POMPANO BEACH, Fla. (PRWEB) April 18, 2018
Prescriber’s Choice, Inc., and its parent, Sincerus Pharmaceuticals (Sincerus), companies that are revolutionizing the delivery of personalized medicine, today announced the selection of LaVoieHealthScience (LHS), a specialized public and investor relations agency focused on advancing health and science innovations, for its strategic communications program aimed at key stakeholders, including dermatology practices, investors, consumers, advocacy groups and professional societies.
“With this new partnership we are excited to boost our visibility and make dermatologists and their patients aware of our powerful pharmaceutical disintermediation. We enable consumers to ‘skip the trip’ to the pharmacy, while drastically reducing consumer costs and delivering customized medications at the point of care. Our proprietary platform and innovative technology provides a complementary solution to physicians and consumers and fills a void that is not currently being addressed by large manufacturers,” said Dr. Spencer Malkin, CEO of Prescriber’s Choice.
Physician prescribing is in the state of crisis. It is estimated that up to a third of prescriptions never get filled. A recent study by the American Medical Association reported that nearly 80 percent of doctors feel prior authorizations are making expensive care more difficult for patients. Seventy-eight percent report that prior authorization can lead to treatment abandonment.
“Prescriber’s Choice is a game-changer in healthcare,” said Donna L. LaVoie, President and CEO of LaVoieHealthScience. “The team at Prescriber’s Choice and Sincerus are smart, pragmatic and focused on providing quality, safety and patient access. Patients need affordable, customized medications along with personalized care and Prescriber’s Choice offers a powerful tool to promote medication adherence, while maintaining safety standards in a CGMP environment.”
About Prescriber’s Choice and Sincerus Pharmaceuticals, Inc.
Prescriber’s Choice is a complete resource for dermatologist point-of-care preparation and dispensing of customized medications. The company enables its dermatology practice customers to personalize medicine in their office and dispense it for patients’ specific needs.
Sincerus Pharmaceuticals, named after the Latin word for purity, is the parent company of Prescriber’s Choice. Sincerus provides outsourced pharmaceutical products in accordance with CGMP standards and has Quality Assurance and Quality Control programs in place to monitor and support all preparations. With today’s healthcare environment demanding a safe, secure and reliable supply chain, it is essential that patients and physicians know the source and process through which these pharmaceuticals are made.
Founded in 2001, LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications. The agency has received 31 awards over the past eight years in recognition of the work it has done for its health and science industry-leading clients and is ranked as a leading independent health PR agency. Follow LHS on Twitter at @LaVoieGroup.
For more information about Prescriber’s Choice & Sincerus
Account Manager, PR & Marketing